$NWPN The Now Corporation (OTC:NWPN) Is Honored To Be Interviewed By Pennystocks.news
Press Release | 08/17/2020
August 17, 2020
OTC Disclosure & News Service
Palm Beach, FL —
This release includes additional documents. Select the link(s) below to view.
The Now Corporation Logo
The Now Corporation is pleased to announce that it is honored to be part of a written interview with Pennystocks.news (PSN) which is a leading provider and publisher of stock market news, initial public offering (IPO) news, new stock listings and stocks to watch, commentary, business news, financial news and content on the USA & World Markets.
A copy of the interview is below:
PSN: What is the short and long term goal for The Now Corporation? And how are you
going to accomplish this?
Answer: The Now Corporation is a publicly traded, bio-pharmaceutical research company committed
to advance the science of cannabis research. With a focus on developing plant-derived
cannabinoid pharmaceutical products, our mission is to improve the health and wellness of
patients worldwide. We are building a dynamic, innovative and forward-looking research,
development, education, and testing company serving the fast growing cannabis industry across
the US and Canada.
In the short term, we have created agreements with top research scientists from major
Universities and have utilized their existing labs to perform expensive research using
cannabinoid compounds which are in cannabis plants. From the research, we will be able to
publish research white papers that will contain credible data from these research laboratories.
As a result, the information that we publish will start to establish increased credibility in the
industry, and will allow our products to be prescribed by physicians since they will be able to
access the information in their databases. These studies will answer many questions and stop
false data and rumors about CBD/THC derived from cannabis, and the effects on the human
In the long term, we desire to have an FDA approved medicine that focuses on nausea and
other ailments. Due to the FDA approval, it will be available for pharmacies to dispense, and
will be on the approved list for insurance companies to pay for. Ultimately, we will pursue
patenting the compound on a molecular level, similar to Pfizers patent on the drug, Viagra.
PSN: As CBD becomes legal and more available across the US, more government regulation
is inevitable. How will The Now Corporation respond to this matter?
Answer: After spending five years leading public companies in the Legal Marijuana
Industry, three decades of Advanced Technology Engineering, and as an Executive
for multimillion dollar brands, I know what truly drives business.
On November 19, 2019, The FDA warned 15 companies for illegally selling various
products containing cannabidiol as the agency details safety concerns. Violations include
marketing unapproved new human and animal drugs, selling CBD products as dietary
supplements, and adding CBD to human and animal foods. Through our research, we will
address the safety concerns by performing rigorous testing of CBD compounds. By publishing
a scientific white paper based on the study, it will allow the FDA to review the information and
have credible data to make concrete rulings. The Federal Government needs to have data
before changing any laws.
PSN: While the CBD products are flooding the market and CBD becomes more available across
the US. How does The Now Corporation make it stand out from the competition?
Answer: We will have a scientifically tested product. The existing products that are available on the
markets are not safe. For example, what is the safe dosing for CBDs in the human body? What
is the effectiveness rate when humans consume CBD, and how much can a human take before
it becomes toxic to the body? The Federal government, along with State governments must find
out this answer before deeming it safe. Our research does not start at the plant, we will also
research air, soil, and water, from a seed genetic level up to a mature plant.
PSN: What can be said about the partnerships The Now Corporation currently has? And why
have they turned out to be so important?
Answer: The Now Corporation leverages its assets and equity holdings/stakes of other
companies which engages in medical and recreational marijuana, technology
development, oil fabrication, exploration and extraction, and education.
As an example, we own 26% of Transglobal Assets Inc. (OTC:TMSH), which has a CBD drink.
This partnership allows us to validate and certify the product for its ingredients, and safety. We
have strategic technology partners that can assist and utilize the most advanced technology
PSN: How would The Now Corporation like to expand its current business? Is there
something concrete in the pipeline like a subsidiary or cooperation?
Answer: Please review the following press release which shows one possible avenue to expansion:
In the pipeline, we are trying to work with both NASA and SpaceX for our research initiatives.
Concerning NASA, we would like to utilize the International Space Station for unique discoveries
of how CBD and THC reacts using animal testing. Cells tend to have a different effects in zero
gravity. Concerning SpaceX, they are aggressive in taking humans to space, for long extended
times, and eventually to Mars. Through our research initiatives, the creation of an organic CBD
nausea drug would be safe and beneficial for astronauts.
PSN: What is the current state of the assets, income and possible debts. In other words, how
healthy is The Now Corporation?
Answer: The Now Corporation is fully current with OTC Markets Group Inc.
We have substantial assets with which to create income. However, to gather these assets and
our exceptional team, we incurred debt. However, once we become more established, we
expect to settle a significant portion of that.
PSN: What has The Now Corporation experienced since the outbreak of COVID-19? And how
did it affect the business?
Answer: My wife and I had friends and family that had the virus and it is devastating health wise. We
provided care and ran errands for the last few months that we will continue to do.
The virus directly affected the business, because attorneys and financial institutions had to
scale back and changed the way they do business, which introduced a level of slowness that we
were unprepared for.
PSN: Why did The Now Corporation enter the stock market? And how do you look back on
this decision and its progress?
Answer: I am the CEO and Managing Director, also serving as Brand and Marketing
Strategist. After spending five years leading public companies in the Legal Marijuana
Industry, three decades of Advanced Technology Engineering, and as an Executive
for multimillion dollar brands, I know what truly drives business. Its how well you
connect with the public to help and communicate for understanding. I have excellent
strategic planning and corporate execution skills.
Being listed on the stock market allows us to express clearly and directly to the shareholders
and investors what we are doing and where we are going. These efforts will allow us to raise
monies to fund projects since performing research is expensive.
PSN: If you look at the share, then we see impressive rises followed by a somewhat roller
coaster effect throughout the year 2020. What are your expectations for the rest of the year?
Answer: I do not like to comment on the share price but I am working fourteen hours a day for seven
days a week building this company. My dedication is second to none.
The presidential election will determine a lot as it will remove various uncertainties for the
company as well as for the industry as a whole.
PSN: Finally, is there anything that we didnt mention about The Now Corporation that you
would like to point out to us?
Answer: I am extremely excited to see RBA Pharma Inc. go public. We expect it to be extremely well
received in the marketplace.
Updates will be forthcoming
The Now Corporation is a publicly traded, bio-pharmaceutical research company focused on the research, education and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purpose, while focusing on pursuing business opportunities in the growing medical and recreational marijuana sector. Through its acquired assets, The Now Corporation is seeking to invest in our businesses associated with the growing, marketing, research and development, training, distribution and retail sale of scientific-grade medicinal cannabis, both in the United States and Canada. At The Now Corporation, we unlock and advance medicine for human life around the world, at every stage of life.